Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-27, Stock:NVS, The news for the past five days is as follows:
2019-06-20: NEWS1: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS2: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS3: From generic drugs to gummies: Boulder CBD company buys Novartis pharmaceutical plant in Broomfield for $18.8M.
2019-06-21: NEWS1: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS2: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS3: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS4: Oh, By the Way, This Clinical Trial Didn't Work.NEWS5: Oh, By the Way, This Clinical Trial Didn't Work.NEWS6: UPDATE 1-U.S. group says Novartis MS drug price out of line with benefit.NEWS7: U.S. group says Novartis MS drug price out of line with benefit.
2019-06-24: NEWS1: UPDATE 1-Conatus Pharma to explore options as liver disease drug fails trial.
2019-06-25: NEWS1: Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS.NEWS2: Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS.NEWS3: Novartis wins Gilenya reprieve as judge blocks generics, for now.
2019-06-26: NEWS1: Is Allergan a Good Deal for AbbVie?.NEWS2: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS3: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS4: Conatus' Emricasan Lags Primary Goal in Liver Function Study.

Answer: Decrease